Stay updated with breaking news from Hookipa Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Royal Bank of Canada reissued their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a report published on Tuesday morning, Benzinga reports. The firm currently has a $5.00 price target on the stock. Separately, HC Wainwright reduced their target price on shares of Hookipa Pharma from $6.50 to $5.00 and set […]
Royal Bank of Canada reaffirmed their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $5.00 price target on the stock. Separately, HC Wainwright reduced their price target on shares of Hookipa Pharma from […]
Penny stocks to buy understandably offers many enticing attributes, not least of which is the potential for tremendous returns.
Hookipa Pharma (NASDAQ:HOOK – Get Free Report) had its price target lowered by research analysts at HC Wainwright from $6.50 to $5.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Separately, Royal Bank of Canada restated an “outperform” rating and […]
Hookipa Pharma (NASDAQ:HOOK – Get Free Report) had its target price decreased by investment analysts at HC Wainwright from $6.50 to $5.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Separately, Royal Bank of Canada reaffirmed an “outperform” rating and […]